Sanofi Announces FDA Approval of Sklice� Lotion for the Treatment of Head Lice - MarketWatch (press release)

Sanofi Announces FDA Approval of Sklice� Lotion for the Treatment of Head Lice MarketWatch (press release) The most common adverse reactions (incidence <1%) were conjunctivitis, ocular hyperemia, eye irritation, dandruff, dry skin and skin burning sensation. The safety of Sklice Lotion has not been established in pediatric patients below the age of 6 months ... and more »

Source: http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHqWvR7PV1Ex9pZl7h_lwnU7vkNWQ&url=http://www.marketwatch.com/story/sanofi-announces-fda-approval-of-sklice-lotion-for-the-treatment-of-head-lice-2012-02-07

skin care women health skin cream